ID   CDT1_HUMAN              Reviewed;         546 AA.
AC   Q9H211; Q86XX9; Q96CJ5; Q96GK5; Q96H67; Q96HE6; Q9BWM0;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   07-APR-2021, entry version 165.
DE   RecName: Full=DNA replication factor Cdt1;
DE   AltName: Full=Double parked homolog;
DE            Short=DUP;
GN   Name=CDT1 {ECO:0000312|EMBL:AAG45181.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAG45181.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, SUBCELLULAR
RP   LOCATION, INTERACTION WITH GMNN, AND VARIANTS ARG-234 AND ALA-262.
RX   PubMed=11125146; DOI=10.1126/science.290.5500.2309;
RA   Wohlschlegel J.A., Dwyer B.T., Dhar S.K., Cvetic C., Walter J.C., Dutta A.;
RT   "Inhibition of eukaryotic DNA replication by geminin binding to Cdt1.";
RL   Science 290:2309-2312(2000).
RN   [2] {ECO:0000312|EMBL:BAB61878.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ARG-234 AND ALA-262.
RX   PubMed=10766248; DOI=10.1038/35007110;
RA   Nishitani H., Lygerou Z., Nishimoto T., Nurse P.;
RT   "The Cdt1 protein is required to license DNA for replication in fission
RT   yeast.";
RL   Nature 404:625-628(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4] {ECO:0000312|EMBL:AAH14202.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-234 AND ALA-262.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH08860.2},
RC   Cervix {ECO:0000312|EMBL:AAH00137.2}, Eye {ECO:0000312|EMBL:AAH08676.1},
RC   Kidney {ECO:0000312|EMBL:AAH14202.2}, Liver {ECO:0000312|EMBL:AAH49205.1},
RC   and Uterus {ECO:0000312|EMBL:AAH09410.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-546, AND VARIANT ARG-234.
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INDUCTION.
RX   PubMed=14990995; DOI=10.1038/sj.onc.1207488;
RA   Yoshida K., Inoue I.;
RT   "Regulation of Geminin and Cdt1 expression by E2F transcription factors.";
RL   Oncogene 23:3802-3812(2004).
RN   [7]
RP   INTERACTION WITH KAT7.
RX   PubMed=18832067; DOI=10.1101/gad.1674108;
RA   Miotto B., Struhl K.;
RT   "HBO1 histone acetylase is a coactivator of the replication licensing
RT   factor Cdt1.";
RL   Genes Dev. 22:2633-2638(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-318, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION AT THR-29; SER-93 AND SER-318 BY MAPK8/JNK1, AND FUNCTION.
RX   PubMed=21856198; DOI=10.1016/j.molcel.2011.06.021;
RA   Miotto B., Struhl K.;
RT   "JNK1 phosphorylation of Cdt1 inhibits recruitment of HBO1 histone
RT   acetylase and blocks replication licensing in response to stress.";
RL   Mol. Cell 44:62-71(2011).
RN   [11]
RP   UBIQUITINATION, AND INTERACTION WITH GMNN.
RX   PubMed=15257290; DOI=10.1038/sj.emboj.7600314;
RA   Ballabeni A., Melixetian M., Zamponi R., Masiero L., Marinoni F., Helin K.;
RT   "Human geminin promotes pre-RC formation and DNA replication by stabilizing
RT   CDT1 in mitosis.";
RL   EMBO J. 23:3122-3132(2004).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH MCM2; GMNN AND CDC6.
RX   PubMed=14672932; DOI=10.1074/jbc.m311933200;
RA   Cook J.G., Chasse D.A.D., Nevins J.R.;
RT   "The regulated association of Cdt1 with minichromosome maintenance proteins
RT   and Cdc6 in mammalian cells.";
RL   J. Biol. Chem. 279:9625-9633(2004).
RN   [13]
RP   FUNCTION, PHOSPHORYLATION, MUTAGENESIS OF 68-ARG--LEU-70, AND INTERACTION
RP   WITH SKP2; GMNN AND CYCLIN A-DEPENDENT KINASES.
RX   PubMed=14993212; DOI=10.1074/jbc.m313175200;
RA   Sugimoto N., Tatsumi Y., Tsurumi T., Matsukage A., Kiyono T., Nishitani H.,
RA   Fujita M.;
RT   "Cdt1 phosphorylation by cyclin A-dependent kinases negatively regulates
RT   its function without affecting geminin binding.";
RL   J. Biol. Chem. 279:19691-19697(2004).
RN   [14]
RP   UBIQUITINATION, AND INTERACTION WITH PCNA.
RX   PubMed=16861906; DOI=10.4161/cc.5.15.3149;
RA   Higa L.A., Banks D., Wu M., Kobayashi R., Sun H., Zhang H.;
RT   "L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates
RT   CDT1 proteolysis in response to DNA damage.";
RL   Cell Cycle 5:1675-1680(2006).
RN   [15]
RP   UBIQUITINATION.
RX   PubMed=17085480; DOI=10.1101/gad.1482106;
RA   Sansam C.L., Shepard J.L., Lai K., Ianari A., Danielian P.S., Amsterdam A.,
RA   Hopkins N., Lees J.A.;
RT   "DTL/CDT2 is essential for both CDT1 regulation and the early G2/M
RT   checkpoint.";
RL   Genes Dev. 20:3117-3129(2006).
RN   [16]
RP   UBIQUITINATION.
RX   PubMed=16949367; DOI=10.1016/j.molcel.2006.08.010;
RA   Jin J., Arias E.E., Chen J., Harper J.W., Walter J.C.;
RT   "A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is
RT   required for S phase destruction of the replication factor Cdt1.";
RL   Mol. Cell 23:709-721(2006).
RN   [17]
RP   INTERACTION WITH GMNN, AND MUTAGENESIS OF TYR-170.
RX   PubMed=21543332; DOI=10.1074/jbc.m110.207688;
RA   Pefani D.E., Dimaki M., Spella M., Karantzelis N., Mitsiki E., Kyrousi C.,
RA   Symeonidou I.E., Perrakis A., Taraviras S., Lygerou Z.;
RT   "Idas, a novel phylogenetically conserved geminin-related protein, binds to
RT   geminin and is required for cell cycle progression.";
RL   J. Biol. Chem. 286:23234-23246(2011).
RN   [18]
RP   INTERACTION WITH LRWD1, AND PHOSPHORYLATION DURING MITOSIS.
RX   PubMed=22645314; DOI=10.1128/mcb.00362-12;
RA   Shen Z., Chakraborty A., Jain A., Giri S., Ha T., Prasanth K.V.,
RA   Prasanth S.G.;
RT   "Dynamic association of ORCA with prereplicative complex components
RT   regulates DNA replication initiation.";
RL   Mol. Cell. Biol. 32:3107-3120(2012).
RN   [19]
RP   FUNCTION IN MITOSIS, SUBCELLULAR LOCATION, AND INTERACTION WITH NDC80.
RX   PubMed=22581055; DOI=10.1038/ncb2489;
RA   Varma D., Chandrasekaran S., Sundin L.J., Reidy K.T., Wan X., Chasse D.A.,
RA   Nevis K.R., DeLuca J.G., Salmon E.D., Cook J.G.;
RT   "Recruitment of the human Cdt1 replication licensing protein by the loop
RT   domain of Hec1 is required for stable kinetochore-microtubule attachment.";
RL   Nat. Cell Biol. 14:593-603(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-380, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   INTERACTION WITH GRWD1.
RX   PubMed=25990725; DOI=10.1093/nar/gkv509;
RA   Sugimoto N., Maehara K., Yoshida K., Yasukouchi S., Osano S., Watanabe S.,
RA   Aizawa M., Yugawa T., Kiyono T., Kurumizaka H., Ohkawa Y., Fujita M.;
RT   "Cdt1-binding protein GRWD1 is a novel histone-binding protein that
RT   facilitates MCM loading through its influence on chromatin architecture.";
RL   Nucleic Acids Res. 43:5898-5911(2015).
RN   [22]
RP   DEUBIQUITINATION BY USP37, AND DEVELOPMENTAL STAGE.
RX   PubMed=27296872; DOI=10.1016/j.molonc.2016.05.008;
RA   Hernandez-Perez S., Cabrera E., Amoedo H., Rodriguez-Acebes S.,
RA   Koundrioukoff S., Debatisse M., Mendez J., Freire R.;
RT   "USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication.";
RL   Mol. Oncol. 10:1196-1206(2016).
RN   [23]
RP   FUNCTION, INTERACTION WITH FAF1, AND SUBCELLULAR LOCATION.
RX   PubMed=26842564; DOI=10.1038/ncomms10612;
RA   Franz A., Pirson P.A., Pilger D., Halder S., Achuthankutty D., Kashkar H.,
RA   Ramadan K., Hoppe T.;
RT   "Chromatin-associated degradation is defined by UBXN-3/FAF1 to safeguard
RT   DNA replication fork progression.";
RL   Nat. Commun. 7:10612-10612(2016).
RN   [24]
RP   VARIANTS MGORS4 THR-66; HIS-117; TRP-453 AND GLN-462.
RX   PubMed=21358632; DOI=10.1038/ng.775;
RA   Bicknell L.S., Bongers E.M., Leitch A., Brown S., Schoots J., Harley M.E.,
RA   Aftimos S., Al-Aama J.Y., Bober M., Brown P.A., van Bokhoven H., Dean J.,
RA   Edrees A.Y., Feingold M., Fryer A., Hoefsloot L.H., Kau N., Knoers N.V.,
RA   Mackenzie J., Opitz J.M., Sarda P., Ross A., Temple I.K., Toutain A.,
RA   Wise C.A., Wright M., Jackson A.P.;
RT   "Mutations in the pre-replication complex cause Meier-Gorlin syndrome.";
RL   Nat. Genet. 43:356-359(2011).
RN   [25]
RP   VARIANT MGORS4 LYS-468.
RX   PubMed=21358631; DOI=10.1038/ng.777;
RA   Guernsey D.L., Matsuoka M., Jiang H., Evans S., Macgillivray C.,
RA   Nightingale M., Perry S., Ferguson M., LeBlanc M., Paquette J., Patry L.,
RA   Rideout A.L., Thomas A., Orr A., McMaster C.R., Michaud J.L., Deal C.,
RA   Langlois S., Superneau D.W., Parkash S., Ludman M., Skidmore D.L.,
RA   Samuels M.E.;
RT   "Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin
RT   syndrome.";
RL   Nat. Genet. 43:360-364(2011).
CC   -!- FUNCTION: Required for both DNA replication and mitosis
CC       (PubMed:11125146, PubMed:22581055, PubMed:21856198, PubMed:14993212,
CC       PubMed:26842564). DNA replication licensing factor, required for pre-
CC       replication complex assembly. Cooperates with CDC6 and the origin
CC       recognition complex (ORC) during G1 phase of the cell cycle to promote
CC       the loading of the mini-chromosome maintenance (MCM) complex onto DNA
CC       to generate pre-replication complexes (pre-RC)(PubMed:14672932).
CC       Required also for mitosis by promoting stable kinetochore-microtubule
CC       attachments (PubMed:22581055). Potential oncogene (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146,
CC       ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212,
CC       ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055,
CC       ECO:0000269|PubMed:26842564}.
CC   -!- SUBUNIT: Interacts with GMNN; inhibits binding of the MCM complex to
CC       origins of replication (PubMed:11125146, PubMed:14672932,
CC       PubMed:14993212, PubMed:15257290). Interacts with CDC6; are mutually
CC       dependent on one another for loading MCM complexes onto chromatin
CC       (PubMed:14672932). Interacts with PCNA (PubMed:16861906). Interacts
CC       with LRWD1 during G1 phase and during mitosis (PubMed:22645314).
CC       Interacts with NDC80 subunit of the NDC80 complex; leading to
CC       kinetochore localization (PubMed:22581055). Interacts with GRWD1;
CC       origin binding of GRWD1 is dependent on CDT1 (PubMed:25990725).
CC       Interacts with KAT7 (PubMed:18832067). Interacts with ubiquitin-binding
CC       protein FAF1; the interaction is likely to promote CDT1 degradation
CC       (PubMed:26842564). {ECO:0000269|PubMed:11125146,
CC       ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212,
CC       ECO:0000269|PubMed:15257290, ECO:0000269|PubMed:16861906,
CC       ECO:0000269|PubMed:18832067, ECO:0000269|PubMed:21543332,
CC       ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:22645314,
CC       ECO:0000269|PubMed:25990725, ECO:0000269|PubMed:26842564}.
CC   -!- INTERACTION:
CC       Q9H211; Q99741: CDC6; NbExp=3; IntAct=EBI-456953, EBI-374862;
CC       Q9H211; O75496: GMNN; NbExp=21; IntAct=EBI-456953, EBI-371669;
CC       Q9H211; Q14566: MCM6; NbExp=4; IntAct=EBI-456953, EBI-374900;
CC       Q9H211; O14777: NDC80; NbExp=7; IntAct=EBI-456953, EBI-715849;
CC       Q9H211; P12004: PCNA; NbExp=2; IntAct=EBI-456953, EBI-358311;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11125146,
CC       ECO:0000269|PubMed:26842564}. Chromosome, centromere, kinetochore
CC       {ECO:0000269|PubMed:22581055}. Note=Transiently localizes to
CC       kinetochores during prometaphase and metaphase.
CC       {ECO:0000269|PubMed:22581055}.
CC   -!- DEVELOPMENTAL STAGE: Present during G1 and early S phase of the cell
CC       cycle. Degraded during the late S, G2, and M phases.
CC       {ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:27296872}.
CC   -!- INDUCTION: Induced by E2F transcription factors (PubMed:14990995).
CC       {ECO:0000269|PubMed:14990995}.
CC   -!- DOMAIN: The PIP-box K+4 motif mediates both the interaction with PCNA
CC       and the recruitment of the DCX(DTL) complex: while the PIP-box
CC       interacts with PCNA, the presence of the K+4 submotif, recruits the
CC       DCX(DTL) complex, leading to its ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9I9A7}.
CC   -!- PTM: Two independent E3 ubiquitin ligase complexes, SCF(SKP2) and the
CC       DCX(DTL) complex, mediated CDT1 degradation in S phase. Ubiquitinated
CC       by the DCX(DTL) complex, in response to DNA damage, leading to its
CC       degradation. Ubiquitination by the DCX(DTL) complex is necessary to
CC       ensure proper cell cycle regulation and is PCNA-dependent: interacts
CC       with PCNA via its PIP-box, while the presence of the containing the
CC       'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to
CC       its degradation. Phosphorylation at Thr-29 by CDK2 targets CDT1 for
CC       ubiquitination by SCF(SKP2) E3 ubiquitin ligase and subsequent
CC       degradation (PubMed:14993212). The interaction with GMNN protects it
CC       against ubiquitination. Deubiquitinated by USP37 (PubMed:27296872).
CC       {ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:15257290,
CC       ECO:0000269|PubMed:16861906, ECO:0000269|PubMed:16949367,
CC       ECO:0000269|PubMed:17085480, ECO:0000269|PubMed:27296872}.
CC   -!- PTM: Phosphorylation by cyclin A-dependent kinases at Thr-29 targets
CC       CDT1 for ubiquitynation by SCF(SKP2) E3 ubiquitin ligase and subsequent
CC       degradation (PubMed:14993212). Phosphorylated at Thr-29 by MAPK8/JNK1,
CC       which blocks replication licensing in response to stress
CC       (PubMed:21856198). Binding to GMNN is not affected by phosphorylation.
CC       {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:14993212,
CC       ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22645314}.
CC   -!- DISEASE: Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]: A syndrome
CC       characterized by bilateral microtia, aplasia/hypoplasia of the
CC       patellae, and severe intrauterine and postnatal growth retardation with
CC       short stature and poor weight gain. Additional clinical findings
CC       include anomalies of cranial sutures, microcephaly, apparently low-set
CC       and simple ears, microstomia, full lips, highly arched or cleft palate,
CC       micrognathia, genitourinary tract anomalies, and various skeletal
CC       anomalies. While almost all cases have primordial dwarfism with
CC       substantial prenatal and postnatal growth retardation, not all cases
CC       have microcephaly, and microtia and absent/hypoplastic patella are
CC       absent in some. Despite the presence of microcephaly, intellect is
CC       usually normal. {ECO:0000269|PubMed:21358631,
CC       ECO:0000269|PubMed:21358632}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Cdt1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AF070552; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDT1ID44175ch16q24.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF321125; AAG45181.1; -; mRNA.
DR   EMBL; AB053172; BAB61878.1; -; mRNA.
DR   EMBL; AC092384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000137; AAH00137.2; -; mRNA.
DR   EMBL; BC008676; AAH08676.1; -; mRNA.
DR   EMBL; BC008860; AAH08860.2; -; mRNA.
DR   EMBL; BC009410; AAH09410.1; -; mRNA.
DR   EMBL; BC014202; AAH14202.2; -; mRNA.
DR   EMBL; BC049205; AAH49205.1; -; mRNA.
DR   EMBL; AF070552; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS32510.1; -.
DR   RefSeq; NP_112190.2; NM_030928.3.
DR   PDB; 2LE8; NMR; -; B=413-440.
DR   PDB; 2WVR; X-ray; 3.30 A; C=1-546.
DR   PDB; 6QCG; X-ray; 3.40 A; G/H/I/J/K/L=1-14.
DR   PDBsum; 2LE8; -.
DR   PDBsum; 2WVR; -.
DR   PDBsum; 6QCG; -.
DR   BMRB; Q9H211; -.
DR   SASBDB; Q9H211; -.
DR   SMR; Q9H211; -.
DR   BioGRID; 123555; 71.
DR   ComplexPortal; CPX-659; CDT1-Geminin complex.
DR   CORUM; Q9H211; -.
DR   DIP; DIP-31089N; -.
DR   IntAct; Q9H211; 31.
DR   MINT; Q9H211; -.
DR   STRING; 9606.ENSP00000301019; -.
DR   MoonProt; Q9H211; -.
DR   iPTMnet; Q9H211; -.
DR   PhosphoSitePlus; Q9H211; -.
DR   BioMuta; CDT1; -.
DR   DMDM; 308153620; -.
DR   EPD; Q9H211; -.
DR   jPOST; Q9H211; -.
DR   MassIVE; Q9H211; -.
DR   MaxQB; Q9H211; -.
DR   PaxDb; Q9H211; -.
DR   PeptideAtlas; Q9H211; -.
DR   PRIDE; Q9H211; -.
DR   ProteomicsDB; 80471; -.
DR   Antibodypedia; 1905; 209 antibodies.
DR   Ensembl; ENST00000301019; ENSP00000301019; ENSG00000167513.
DR   GeneID; 81620; -.
DR   KEGG; hsa:81620; -.
DR   UCSC; uc002flu.4; human.
DR   CTD; 81620; -.
DR   DisGeNET; 81620; -.
DR   GeneCards; CDT1; -.
DR   HGNC; HGNC:24576; CDT1.
DR   HPA; ENSG00000167513; Group enriched (bone marrow, esophagus).
DR   MalaCards; CDT1; -.
DR   MIM; 605525; gene.
DR   MIM; 613804; phenotype.
DR   neXtProt; NX_Q9H211; -.
DR   OpenTargets; ENSG00000167513; -.
DR   Orphanet; 2554; Ear-patella-short stature syndrome.
DR   PharmGKB; PA145008572; -.
DR   VEuPathDB; HostDB:ENSG00000167513.8; -.
DR   eggNOG; KOG4762; Eukaryota.
DR   GeneTree; ENSGT00390000012337; -.
DR   HOGENOM; CLU_023373_1_0_1; -.
DR   InParanoid; Q9H211; -.
DR   OMA; MEQRRVT; -.
DR   OrthoDB; 648388at2759; -.
DR   PhylomeDB; Q9H211; -.
DR   TreeFam; TF101159; -.
DR   PathwayCommons; Q9H211; -.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68867; Assembly of the pre-replicative complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.
DR   SIGNOR; Q9H211; -.
DR   BioGRID-ORCS; 81620; 775 hits in 1004 CRISPR screens.
DR   ChiTaRS; CDT1; human.
DR   EvolutionaryTrace; Q9H211; -.
DR   GeneWiki; DNA_replication_factor_CDT1; -.
DR   GenomeRNAi; 81620; -.
DR   Pharos; Q9H211; Tbio.
DR   PRO; PR:Q9H211; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9H211; protein.
DR   Bgee; ENSG00000167513; Expressed in mucosa of paranasal sinus and 155 other tissues.
DR   ExpressionAtlas; Q9H211; baseline and differential.
DR   Genevisible; Q9H211; HS.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000776; C:kinetochore; IDA:CAFA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:CAFA.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0070182; F:DNA polymerase binding; IBA:GO_Central.
DR   GO; GO:0051315; P:attachment of mitotic spindle microtubules to kinetochore; IMP:UniProtKB.
DR   GO; GO:0051301; P:cell division; IMP:CAFA.
DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.
DR   GO; GO:1902426; P:deactivation of mitotic spindle assembly checkpoint; IMP:CAFA.
DR   GO; GO:0000076; P:DNA replication checkpoint; IDA:UniProtKB.
DR   GO; GO:0006270; P:DNA replication initiation; TAS:Reactome.
DR   GO; GO:0071163; P:DNA replication preinitiation complex assembly; IDA:CAFA.
DR   GO; GO:0051383; P:kinetochore organization; IMP:CAFA.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:1905341; P:negative regulation of protein localization to kinetochore; IMP:CAFA.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; IDA:CAFA.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:2000105; P:positive regulation of DNA-dependent DNA replication; IDA:CAFA.
DR   GO; GO:1905342; P:positive regulation of protein localization to kinetochore; IMP:CAFA.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; IMP:CAFA.
DR   GO; GO:0036388; P:pre-replicative complex assembly; TAS:Reactome.
DR   GO; GO:0033044; P:regulation of chromosome organization; IMP:CAFA.
DR   GO; GO:1902595; P:regulation of DNA replication origin binding; IDA:CAFA.
DR   GO; GO:0030174; P:regulation of DNA-dependent DNA replication initiation; IDA:UniProtKB.
DR   GO; GO:0033262; P:regulation of nuclear cell cycle DNA replication; IEA:Ensembl.
DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0072708; P:response to sorbitol; IDA:CAFA.
DR   DisProt; DP01193; -.
DR   InterPro; IPR032054; Cdt1_C.
DR   InterPro; IPR014939; CDT1_Gemini-bd-like.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF08839; CDT1; 1.
DR   Pfam; PF16679; CDT1_C; 1.
DR   SMART; SM01075; CDT1; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell cycle; Cell division; Centromere; Chromosome;
KW   Disease variant; DNA replication; Dwarfism; Kinetochore; Mitosis; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; Ubl conjugation.
FT   CHAIN           1..546
FT                   /note="DNA replication factor Cdt1"
FT                   /id="PRO_0000191619"
FT   REGION          150..190
FT                   /note="Interaction with GMNN"
FT   REGION          451..546
FT                   /note="Interaction with LRWD1"
FT                   /evidence="ECO:0000269|PubMed:22645314"
FT   MOTIF           1..23
FT                   /note="PIP-box K+4 motif"
FT   MOTIF           68..70
FT                   /note="Cyclin-binding motif"
FT   MOD_RES         29
FT                   /note="Phosphothreonine; by MAPK8"
FT                   /evidence="ECO:0000269|PubMed:21856198"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         93
FT                   /note="Phosphoserine; by MAPK8"
FT                   /evidence="ECO:0000269|PubMed:21856198"
FT   MOD_RES         318
FT                   /note="Phosphoserine; by MAPK8"
FT                   /evidence="ECO:0000269|PubMed:21856198,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VARIANT         66
FT                   /note="A -> T (in MGORS4; dbSNP:rs387906918)"
FT                   /evidence="ECO:0000269|PubMed:21358632"
FT                   /id="VAR_065488"
FT   VARIANT         117
FT                   /note="Q -> H (in MGORS4; dbSNP:rs779871947)"
FT                   /evidence="ECO:0000269|PubMed:21358632"
FT                   /id="VAR_065489"
FT   VARIANT         135
FT                   /note="A -> V (in dbSNP:rs3218725)"
FT                   /id="VAR_029163"
FT   VARIANT         172
FT                   /note="R -> C (in dbSNP:rs3218727)"
FT                   /id="VAR_029164"
FT   VARIANT         234
FT                   /note="C -> R (in dbSNP:rs507329)"
FT                   /evidence="ECO:0000269|PubMed:10766248,
FT                   ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_054504"
FT   VARIANT         262
FT                   /note="T -> A (in dbSNP:rs480727)"
FT                   /evidence="ECO:0000269|PubMed:10766248,
FT                   ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_054505"
FT   VARIANT         453
FT                   /note="R -> W (in MGORS4; dbSNP:rs200672589)"
FT                   /evidence="ECO:0000269|PubMed:21358632"
FT                   /id="VAR_065490"
FT   VARIANT         456
FT                   /note="E -> A (in dbSNP:rs3218729)"
FT                   /id="VAR_029165"
FT   VARIANT         462
FT                   /note="R -> Q (in MGORS4; dbSNP:rs387906917)"
FT                   /evidence="ECO:0000269|PubMed:21358632"
FT                   /id="VAR_065491"
FT   VARIANT         468
FT                   /note="E -> K (in MGORS4; dbSNP:rs200652608)"
FT                   /evidence="ECO:0000269|PubMed:21358631"
FT                   /id="VAR_065492"
FT   VARIANT         537
FT                   /note="A -> V (in dbSNP:rs3218721)"
FT                   /id="VAR_024408"
FT   MUTAGEN         68..70
FT                   /note="RRL->AAA: Abolishes binding of cyclin A-dependent
FT                   protein kinases."
FT                   /evidence="ECO:0000269|PubMed:14993212"
FT   MUTAGEN         170
FT                   /note="Y->A: Alters interaction with GMNN."
FT                   /evidence="ECO:0000269|PubMed:21543332"
FT   CONFLICT        494
FT                   /note="E -> K (in Ref. 4; AAH49205)"
FT                   /evidence="ECO:0000305"
FT   TURN            6..9
FT                   /evidence="ECO:0007744|PDB:6QCG"
FT   HELIX           169..172
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           174..177
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   STRAND          180..182
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           188..209
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           216..227
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           233..242
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           244..246
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   STRAND          247..251
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   STRAND          269..273
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           288..314
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   TURN            315..319
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           325..327
FT                   /evidence="ECO:0007744|PDB:2WVR"
FT   HELIX           420..423
FT                   /evidence="ECO:0007744|PDB:2LE8"
FT   HELIX           425..435
FT                   /evidence="ECO:0007744|PDB:2LE8"
SQ   SEQUENCE   546 AA;  60390 MW;  8179D0330C135FB7 CRC64;
     MEQRRVTDFF ARRRPGPPRI APPKLACRTP SPARPALRAP ASATSGSRKR ARPPAAPGRD
     QARPPARRRL RLSVDEVSSP STPEAPDIPA CPSPGQKIKK STPAAGQPPH LTSAQDQDTI
     SELASCLQRA RELGARVRAL KASAQDAGES CTPEAEGRPE EPCGEKAPAY QRFHALAQPG
     LPGLVLPYKY QVLAEMFRSM DTIVGMLHNR SETPTFAKVQ RGVQDMMRRR FEECNVGQIK
     TVYPASYRFR QERSVPTFKD GTRRSDYQLT IEPLLEQEAD GAAPQLTASR LLQRRQIFSQ
     KLVEHVKEHH KAFLASLSPA MVVPEDQLTR WHPRFNVDEV PDIEPAALPQ PPATEKLTTA
     QEVLARARNL ISPRMEKALS QLALRSAAPS SPGSPRPALP ATPPATPPAA SPSALKGVSQ
     DLLERIRAKE AQKQLAQMTR CPEQEQRLQR LERLPELARV LRSVFVSERK PALSMEVACA
     RMVGSCCTIM SPGEMEKHLL LLSELLPDWL SLHRIRTDTY VKLDKAADLA HITARLAHQT
     RAEEGL
//
